Referenties

ACPO Drugs Committee (2002), A review of drugs policy and proposals for the future, The Association of Chief Police Officers, Londen.

Bossong, M.G., Van Dijk, J.P. en Niesink, R.J.M. (2005), ‘Methylone and mCPP, two new drugs of abuse?’, Addiction biology 10(4), blz. 321-323.

Burrell, K., Jones, L., Sumnall, H. et al. (2005), Tiered approach to drug prevention and treatment among young people, National Collaborating Centre for Drug Prevention, Liverpool.

Chen, C.-Y., O’Brien, M.S. en Anthony, J.C. (2005), ‘Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001’, Drug and alcohol dependence 79, blz. 11-22.

Chivite-Matthews, N., Richardson, A., O’Shea, J. et al. (2005), Drug misuse declared: findings from the 2003/04 British Crime Survey. Home Office statistical bulletin 04/05, Home Office, Londen (http://www.homeoffice.gov.uk/rds/pdfs05/hosb0405.pdf).

CND (2005), World drug situation with regard to drug trafficking: Report of the Secretariat, Commissie voor verdovende middelen van de Economische en Sociale Raad van de Verenigde Naties, Wenen.

CND (2006), World drug situation with regard to drug trafficking: Report of the Secretariat, Commission voor verdovende middelen van de Economische en Sociale Raad van de Verenigde Naties, Wenen.

EuroHIV (2005), HIV/AIDS surveillance in Europe: End-year report 2004. Institute de Veille Sanitaire, Saint-Maurice, nr. 71.

Europol (2006), ‘Drugs 2006’ (mededeling aan het EWDD van 16 januari 2006, file nr. 158448), Europol, Den Haag.

EWDD (2002a), Prosecution of drug users in Europe – varying pathways to similar objectives, Europees Waarnemingscentrum voor drugs en drugsverslaving, Lissabon.

EWDD (2002b), ‘Mortality of drug users in the EU: coordination of implementation of new cohort studies, follow-up and analysis of existing cohorts and development of new methods and outputs’, Project CT.00.EP.13, Europees Waarnemingscentrum voor drugs en drugsverslaving, Lissabon.

EWDD (2004a), 2004 Annual report on the drugs problem in the European Union and Norway, Europees Waarnemingscentrum voor drugs en drugsverslaving, Lissabon.

EWDD (2004b), An overview of cannabis potency in Europe, Insights nr. 6, Europees Waarnemingscentrum voor drugs en drugsverslaving, Lissabon.

EWDD (2004c), European report on drug consumption rooms, Europees Waarnemingscentrum voor drugs en drugsverslaving, Lissabon.

EWDD (2004d), ‘Overdose: a major cause of avoidable death among young people’, Drugs in Focus nr. 13, Europees Waarnemingscentrum voor drugs en drugsverslaving, Lissabon.

EWDD (2005a), Jaarverslag 2005: Stand van de drugsproblematiek in Europa, Europees Waarnemingscentrum voor drugs en drugsverslaving, Lissabon.

EWDD (2005b),’Assistance to EMCDDA for the analysis of drug profiles from EMCDDA Databank on surveys of drug use’, eindverslag, project CT.03.P1.200, Europees Waarnemingscentrum voor drugs en drugsverslaving, Lissabon.

EWDD (2005c), ‘Data collection to develop an inventory of social and health policies, measures and actions concerning drug users in prison in the recently incorporated Member States to the EU’, eindverslag, project CT.04.P2.329, Europees Waarnemingscentrum voor drugs en drugsverslaving, Lissabon.

Farrell, M., Gowing, L., Marsden, J. et al. (2005), ‘Effectiveness of drug dependence treatment in HIV prevention’, International journal of drug policy 16S, blz. S67-75.

Haasen, C., Prinzleve, M., Gossop, M. et al. (2005), ‘Relationship between cocaine use and mental health problems in a sample of European cocaine powder or crack users’, World psychiatry, “4(3), blz. 173-6”.

Hibell, B., Andersson, B., Bjarnasson, T. et al. (2004), The ESPAD report 2003: alcohol and other drug use among students in 35 European countries, Zweedse Raad voor informatie over alcohol en andere drugs (CAN) en de Pompidou-groep van de Raad van Europa.

Higgins, S.T., Sigmon, S.C., Wong, C.J. et al. (2003), ‘Community reinforcement therapy for cocaine-dependent outpatients’, Archives of general psychiatry 60, blz. 1043-1052.

INCB (2006a), Report of the International Narcotics Control Board for 2005, Internationaal Comité van toezicht op verdovende middelen van de Verenigde Naties, New York.

INCB (2006b), Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, Internationaal Comité van toezicht op verdovende middelen van de Verenigde Naties, New York.

Kandel, D. en Davis, M. (1992), ‘Progression to regular marijuana involvement: Phenomenology and risk factors for near daily use’, in: Glantz, M. and Pickens, R. (eds), Vulnerability to Drug Abuse, blz. 211-253. American Psychological Association. Washington.

Kumpfer, K.L., Molgaard, V. en Spoth, R. (1996), ‘The Strengthening Families Program for prevention of delinquency and drug use in special populations’, in: Peters, R. and McMahon, R. J. (eds), Childhood disorders, substance abuse, and delinquency: prevention and early intervention approaches, Sage Publications, Newbury Park, CA.

MacDonald, Z., Tinsley, L., Collingwood, J. et al. (2005), Measuring the harm from illegal drugs using the drug harm index. Home Office Online Report 24/05. Home Office, Londen (http://www.homeoffice.gov.uk/rds/pdfs05/rdsolr2405.pdf).

Naber, D. en Haasen, C. (2006), Das bundesdeutsche Modellprojekt zur heroingestützten Behandlung Opiatabhängiger – eine multizentrische, randomisierte, kontrollierte Therapiestudie, Hamburg, Zentrum für interdisziplinäre Suchtforschung der Universität Hamburg (http://www.heroinstudie.de/ZIS_H-Bericht_P1_DLR.pdf).

ONS (2006), Health Statistics Quarterly 29, Office for National Statistics, Londen.

Poling, J., Oliveto, A., Petry, N. et al. (2006), ‘Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population’, Archives of general psychiatry 63, blz. 219-228.

Prinzleve, M., Haasen, C., Zurhold, H. et al. (2004), ‘Cocaine use in Europe – a multi-centre study: patterns of use in different groups’, European addiction research 10, blz.147-155.

Nationale Reitox-verslagen (2005) (http://www.emcdda.europa.eu/?nnodeid=435).

Roe, E. en Becker, J (2005), ‘Drug prevention with vulnerable young people: a review’, Drugs: education, prevention and policy, 12(2), blz. 85-99.

Roozen, H.G., Boulogne, J.J., van Tulder, M.W. et al. (2004), ‘A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction,’ Drug and alcohol dependence 74, blz. 1-13.

Schäfer, C. en Paoli, L. (2006), Drogenkonsum und Strafverfolgungspraxis, Duncker & Humblot, Berlijn.

Schottenfeld, R.S., Chawarski, M.C., Pakes, J.R. et al. (2005), ‘Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence’, American journal of psychiatry 162, blz. 340-349.

Shearer, J. en Gowing, L.R. (2004), ‘Pharmacotherapies for problematic psychostimulant use: a review of current research’, Drug and alcohol review 23, blz. 203-211.

UNODC (2003a), Global illicit drug trends 2003, Bureau voor drugs en criminaliteit van de Verenigde Naties, Wenen.

UNODC (2003b), Ecstasy and amphetamines: global survey 2003, Bureau voor drugs en criminaliteit van de Verenigde Naties, Wenen.

UNODC (2005), Coca cultivation in the Andean region: A survey of Bolivia, Colombia and Peru – June 2005, Bureau voor drugs en criminaliteit van de Verenigde Naties, Wenen.

UNODC (2006), 2006 world drug report, Bureau voor drugs en criminaliteit van de Verenigde Naties, Wenen.

UNODC en de regering van Marokko (2005), Morocco Cannabis Survey 2004. Bureau voor drugs en criminaliteit van de Verenigde Naties, Wenen.

Van den Brink, W. (2005), ‘Epidemiology of cocaine and crack: implications for drug policy and treatment’, Sucht 51(4), blz. 196-198.

Vickerman, P., Hickman, M., Rhodes, T. en Watts, C. (2006), ‘Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users’, Journal of Acquired Immune Deficiency Syndromes (ter perse).

Von Sydow, K., Lieb, R., Pfister, H. et al. (2002), ‘What predicts incident use of cannabis and progression to abuse and dependence? A 4-year prospective examination of risk factors in a community sample of adolescents and young adults’, Drug and alcohol dependence 68(1), blz. 49-64.

WCO (2005), Customs and drugs 2004, Werelddouaneorganisatie, Brussel.

WHO (2005), Effectiveness of drug dependence treatment in preventing HIV among injecting drug users. Evidence for action technical papers, Wereldgezondheidsorganisatie, Genève.

WHO/UNODC/UNAIDS (2004), ‘Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention’, position paper, Wereldgezondheidsorganisatie, Bureau voor drugs en criminaliteit van de Verenigde Naties, UNAIDS (http://www.who.int/substance_abuse/publications/treatment/en/index.html).